Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K).
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25385636.
- Also identified by DOI 10.1073/pnas.1420281111 and PMC identifier 4250105.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Expression of the regulatory subunit p85β of PI3K induces oncogenic transformation of primary avian fibroblasts. The transformed cells proliferate at an increased rate compared with nontransformed controls and show elevated levels of PI3K signaling. The oncogenic activity of p85β requires an active PI3K-TOR signaling cascade and is mediated by the p110α and p110β isoforms of the PI3K catalytic subunit. The data suggest that p85β is a less effective inhibitor of the PI3K catalytic subunit than p85α and that this reduced level of p110 inhibition accounts for the oncogenic activity of p85β.
Medical subject headings
- Oncogenes
- Phosphatidylinositol 3-Kinase